Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Conditions: Myocardial Infarction; Acute Coronary Syndrome; Diabetes; Ventricular Dysfunction Interventions: Drug: Placebo; Drug: Dapagliflozin Sponsors: University of Sao Paulo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 29, 2024 Category: Research Source Type: clinical trials
Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Conditions: Chronic Kidney Diseases; Type 2 Diabetes Mellitus Interventions: Drug: Dapagliflozin 10 mg Tab; Behavioral: Low protein diet Sponsors: Anemia Working Group Romania; Sf Ioan Emergency Clinical Hospital, Nephrology and Dialysis Department, Bucharest, Romania; Dr Carol Davila Teaching Hospital of Nephrology, Nephrology Department, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK
Conditions: Liver Cirrhosis Interventions: Drug: Placebo (placebo matching zibotentan capsule and placebo matching dapagliflozin tablet); Drug: Zibotentan + placebo (placebo matching dapagliflozin tablet); Drug: Zibotentan + dapagliflozin Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Conditions: Chronic Kidney Disease and Hypertension Interventions: Drug: Baxdrostat/dapagliflozin; Drug: Dapagliflozin in combination with placebo Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Anti-Diabetic Medications to Fight PD and LBD
Conditions: Lewy Body Dementia; Parkinson Disease Interventions: Drug: Sitagliptin; Drug: Dapagliflozin; Drug: Placebo Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers
Conditions: Diabetes Mellitus Interventions: Drug: Vitamin B12 0.5 MG/ACTUAT; Drug: Dapagliflozin 10mg Tab Sponsors: Al-Balqa Applied University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Dapagliflozin Tablet 10 mg Relative to Forxiga ® Tablets 10 mg
Conditions: Healthy Subjects Interventions: Drug: Dapagliflozin-Test product; Drug: Dapagliflozin-Reference product Sponsors: Bio-innova Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Effects of Dapagliflozin on Progression of Alport Syndrome
Conditions: Alport Syndrome Interventions: Drug: Dapagliflozin 10mg Tab Sponsors: Nanjing University School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease (CKD) Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients
Conditions: Genetic Polymorphisms; Heart Failure Interventions: Drug: SGLT2 inhibitors (Dapagliflozin and Empagliflozin) Sponsors: October 6 University; University of Florida; National Heart Institute, Egypt; Beni-Suef University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Conditions: Type 2 Diabetes Interventions: Drug: Orforglipron; Drug: Dapagliflozin Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Treatment of Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease Interventions: Drug: lisinopril, enalapril; Drug: dapagliflozin, empagliflozin Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
Dapagliflozin in STEMI Randomized Clinical Trial
Conditions: ST Elevation Myocardial Infarction; Myocardial Infarction Interventions: Drug: Dapagliflozin 10mg Tab; Diagnostic Test: CMR Sponsors: Ottawa Heart Institute Research Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
Proteinuria in Renal Transplant Patients Treated With Dapagliflozin
Conditions: Chronic Kidney Diseases Interventions: Procedure: Follow-up at D14; Procedure: Follow-up at M1 Sponsors: University Hospital, Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Conditions: Lupus Nephritis; Chronic Kidney Diseases Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Standard maintenance therapy Sponsors: The University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
